ea0026p461 | Thyroid cancer | ECE2011
Serra M P
, Alonso O
, Delos Santos C
, Hermida J C
, Quagliata A
, Gambini J P
, Tochetto Y
, Gonzalez G
Introduction: Patients bearing thyroid cancer that have already gone into surgery and 131I therapy that in the follow-up have high thyroglobulin levels and negative 131I whole body scan represent a diagnostic and therapeutic challenge. 99mTc HYNIC Octreotide recognizes somatostatin receptors that are expressed in thyroid cancer. The objective of this paper is to evaluate these patients by means of 99mTc HYNIC Octreotide and to correlate the results with other imaging methods.<...